Dermal Filler Market Size By Type (Biodegradable {Temporary Biodegradable, Semi-permanent Biodegradable}, Non-biodegradable), By Material Type (Hyaluronic Acid {HA}, Calcium Hydroxylapatite {CaHA}, Poly-L-lactic Acid, Polymethyl-methacrylate Microspheres

Dermal Filler Market Size By Type (Biodegradable {Temporary Biodegradable, Semi-permanent Biodegradable}, Non-biodegradable), By Material Type (Hyaluronic Acid {HA}, Calcium Hydroxylapatite {CaHA}, Poly-L-lactic Acid, Polymethyl-methacrylate Microspheres {PMMA}), By Application (Facial Line Correction, Face Lift, Lip Enhancement), By End-use (Dermatology Clinics, Hospitals), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028

The dermal filler market is anticipated to witness robust growth by 2028 owing to rising demand for minimally-invasive aesthetic procedures, particularly in developed countries.

Recently, industry players have been focusing on product development, which has positively influenced market outlook. For instance, in June 2021, Galderma, a key pharmaceutical company, announced that it received U.S. Food and Drug Administration (FDA) approval for Restylane Contour, a novel hyaluronic acid (HA) dermal filler. Restylane Contour is the firm’s first product in the U.S. made using the XpresHAn Technology for the cheek.

Moreover, during the COVID 19 pandemic, the market witnessed a decrease in the demand for dermal fillers due to decline in the number of cosmetic treatments as stringent lockdown restrictions were imposed by the government. However, due to prevalent vaccination drives worldwide, the market is gradually rebounding.

The dermal filler market has further been segmented on the basis of type, material type, application, end-use, and region. Based on type, the market has been divided into biodegradable and non-biodegradable. The non-biodegradable sub-segment held a sizable share in the market in 2021 and is likely to grow at a steady pace over 2022-2028. Permanent/non-biodegradable fillers offer long-lasting results, which is set to boost segmental growth.

With respect to material type, the dermal filler market has been categorized into polymethyl-methacrylate microspheres (PMMA), hyaluronic acid (HA), poly-L-lactic acid, calcium hydroxylapatite, and others. In 2021, the hyaluronic acid (HA) sub-segment held over 95% share in the market and is poised to see substantial growth over the analysis timespan. High biocompatibility and robust hyaluronic acid-based products available in the market is expected to boost segmental development.

In terms of application, the market has been divided into facial line correction, face lift, lip enhancement, and others. The facial line correction sub-segment is anticipated to witness substantial growth by 2028, registering a CAGR of over 10.5% through the review timeline. The development of novel dermal fillers as well as the expanding elderly population are estimated to contribute to the segment's growth.

In terms of end-use, the dermal filler market has been divided into dermatology clinics, hospitals, and others. The hospitals sub-segment is expected to see robust growth over the forecast period on account of increasing number of aesthetic treatments, mounting availability of technologically advanced devices, and rising presence of highly competent plastic surgeons.

From the regional point of view, the Latin America dermal filler market is anticipated to witness significant growth at a CAGR of about 9.9% over the forecast timeline to attain a sizable share in the overall industry by the end of 2028. Increasing financial capabilities, surge in the number of men getting cosmetic treatments, and soaring demand for non-invasive aesthetic procedures in LATAM, particularly in Brazil, are projected to contribute to regional market growth.